See more : Montauk Renewables, Inc. (MNTK) Income Statement Analysis – Financial Results
Complete financial analysis of Primo Nutraceuticals Inc. (BUGVF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Primo Nutraceuticals Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Taiwan Takisawa Technology Co., Ltd. (6609.TWO) Income Statement Analysis – Financial Results
- Harvest Gold Corporation (HVGDF) Income Statement Analysis – Financial Results
- Doxee S.p.A. (DOX.MI) Income Statement Analysis – Financial Results
- Tejnaksh Healthcare Limited (TEJNAKSH.BO) Income Statement Analysis – Financial Results
- Aisin Corporation (ASEKY) Income Statement Analysis – Financial Results
Primo Nutraceuticals Inc. (BUGVF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.primonutraceuticals.com
About Primo Nutraceuticals Inc.
Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 1.20M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 196.20K |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 1.40M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -1.19M |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 1.19M |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 1.19M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 1.89K |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -1.19M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -1.19M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -2.68M |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -3.87M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | -1.38K |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -3.87M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.88 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.88 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 4.38M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 4.38M |
Source: https://incomestatements.info
Category: Stock Reports